Timber pharmaceuticals to present at the h.c. wainwright 23rd annual global investment conference

Basking ridge, nj, sept. 10, 2021 (globe newswire) -- via newmediawire – timber pharmaceuticals, inc. ("timber" or the “company”) (nyse american: tmbr), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it will present at the h.c. wainwright 23rd annual global investment conference. the conference will be held virtually with all participants joining remotely from september 13th - 15th, 2021.
TMBR Ratings Summary
TMBR Quant Ranking